Aurobindo Pharma Limited (NSE:AUROPHARMA)
India · Delayed Price · Currency is INR 1,079.30
-11.10 (-1.02%)
Aug 5, 2025, 3:30 PM IST
Aurobindo Pharma Employees
Aurobindo Pharma had 26,015 employees as of March 31, 2024. The number of employees increased by 2,564 or 10.93% compared to the previous year.
Employees
26,015
Change (1Y)
2,564
Growth (1Y)
10.93%
Revenue / Employee
12.31M INR
Profits / Employee
1.30M INR
Market Cap
626.86B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 26,015 | 2,564 | 10.93% |
| Mar 31, 2023 | 23,451 | 8,020 | 51.97% |
| Mar 31, 2022 | 15,431 | -3,933 | -20.31% |
| Mar 31, 2021 | 19,364 | 895 | 4.85% |
| Mar 31, 2020 | 18,469 | 614 | 3.44% |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Divi's Laboratories | 10,542 |
| Cipla | 30,313 |
| Mankind Pharma | 26,978 |
| Apollo Hospitals Enterprise | 83,147 |
| Zydus Lifesciences | 27,917 |
| Fortis Healthcare | 12,237 |
| Alkem Laboratories | 18,785 |
Aurobindo Pharma News
- 20 hours ago - Aurobindo Pharma share: Macquarie downgrades to underperform, flags US business concerns - Business Upturn
- 1 day ago - Aurobindo Pharma board declares interim dividend of Rs 4 per share for FY26 - Business Upturn
- 1 day ago - Top Q1 results today, August 4: Shree Cements, Aurobindo Pharma, DLF, Marico, Godfrey Phillips and more to announce earnings - Business Upturn
- 5 days ago - Amid Trump tariff fears, Aurobindo strikes biggest deal; To acquire Lannett for Rs 2185 crore - The Times of India
- 19 days ago - Amicus gains as Morgan Stanley upgrades on Aurobindo case and Pom-Op switching - Seeking Alpha
- 4 weeks ago - Aurobindo Pharma shares slip nearly 3% after Macquarie downgrades stock, cuts target price to Rs 1,010 - Business Upturn
- 4 weeks ago - Top stocks in focus on July 3: Nestle India, Aurobindo Pharma, Hindustan Zinc, V2 Retail, CSB Bank and more - Business Upturn
- 4 weeks ago - Aurobindo Pharma’s subsidiary CuraTeQ Biologics secures marketing approval for trastuzumab biosimilar ‘Dazublys’ - Business Upturn